Cargando…
Immunogenicity of human embryonic stem cell-derived beta cells
AIMS/HYPOTHESIS: To overcome the donor shortage in the treatment of advanced type 1 diabetes by islet transplantation, human embryonic stem cells (hESCs) show great potential as an unlimited alternative source of beta cells. hESCs may have immune privileged properties and it is important to determin...
Autores principales: | van der Torren, Cornelis R., Zaldumbide, Arnaud, Duinkerken, Gaby, Brand-Schaaf, Simone H., Peakman, Mark, Stangé, Geert, Martinson, Laura, Kroon, Evert, Brandon, Eugene P., Pipeleers, Daniel, Roep, Bart O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518073/ https://www.ncbi.nlm.nih.gov/pubmed/27787618 http://dx.doi.org/10.1007/s00125-016-4125-y |
Ejemplares similares
-
Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy
por: van der Torren, Cornelis R., et al.
Publicado: (2015) -
Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
por: van der Torren, Cornelis R., et al.
Publicado: (2016) -
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
por: Roep, Bart O., et al.
Publicado: (2020) -
Islet stress, degradation and autoimmunity
por: Thomaidou, Sofia, et al.
Publicado: (2018) -
Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control
por: Robert, Thomas, et al.
Publicado: (2018)